logo BDSP

Base documentaire

  1. Economic evaluation of ondansetron : preliminary analysis using clinical trial data to price setting.

    Article - En anglais

    This study combines secondary analysis of efficacy and side-effect data from a randomised controlled trial with estimates of resource use to evaluate the likely economic effects of the new antiemetic agent ondansetron.

    Costs, effects and cost-effectiveness of ondansetron in the prophylaxis of acute nausea and vomiting induced by chemotherapy are assessed relative to antiemetic therapy with metoclopramide.

    Superior efficacy of ondansetron is quantified both in terms of significant emesis avoided and emesis management costs avoided.

    Mots-clés Pascal : Tumeur maligne, Vomissement, Ondansétrone, Toxicité, Anticancéreux, Complication, Analyse coût efficacité, Appareil digestif pathologie, Economie santé, Chimiothérapie, Traitement, Homme

    Mots-clés Pascal anglais : Malignant tumor, Vomiting, Toxicity, Antineoplastic agent, Complication, Cost efficiency analysis, Digestive diseases, Health economy, Chemotherapy, Treatment, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 93-0157415

    Code Inist : 002B02H. Création : 199406.